Inovio Pharmaceuticals, Inc.
Pharmaceutical company · Plymouth Meeting, Pennsylvania, United States · Nasdaq: INO
Inovio Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Plymouth Meeting, Pennsylvania, United States. Its shares trade on Nasdaq under the ticker INO. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2020.
Inovio Pharmaceuticals at a glance
What does Inovio Pharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4 million sold (2020).
Frequently asked questions about Inovio Pharmaceuticals
Where is Inovio Pharmaceuticals headquartered?
Inovio Pharmaceuticals, Inc. is headquartered in Plymouth Meeting, Pennsylvania, United States.
What does Inovio Pharmaceuticals do?
Inovio Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Inovio Pharmaceuticals a public company?
Yes. Inovio Pharmaceuticals, Inc. trades on Nasdaq under the ticker INO.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.